Stay updated on BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial
Sign up to get notified when there's something new on the BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial page.

Latest updates to the BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial page
- CheckyesterdayChange DetectedThe site revision label updates from v3.8.0 to v3.8.1, with no apparent changes to the clinical trial record.SummaryDifference0.0%

- Check8 days agoChange DetectedThe record for the completed Phase 2 pegozafermin study is displayed, including its design, eligibility criteria, study locations, outcome measures, and results-related information.SummaryDifference70%

- Check15 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide NIH announcement banner appears above the page, and the footer revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check43 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page has removed several study documents and related metadata (e.g., Statistical Analysis Plan, Study Protocol, IPD sharing plan) and associated update/history items. This reduces visibility of the study's procedures and reporting details.SummaryDifference18%

Stay in the know with updates to BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIO89-100 in Severe Hypertriglyceridemia: Clinical Trial page.